Table 3.
Risk factors for AKI and severe complications (severe acute kidney injury, invasive/non-invasive ventilation, encephalopathy, shock or death)
| Baseline variable | Univariate logistic regression | ||
|---|---|---|---|
| Outcome: AKI (n/N = 25/73)* | Odds ratio | 95% CI | P |
| Age, years | 0.91 | 0.81, 1.04 | 0.16 |
| Sex, boys | 0.56 | 0.11, 2.85 | 0.49 |
| Nephrotic syndrome in relapse | 3.62 | 1.01, 12.99 | 0.048 |
| Estimated glomerular filtration rate, ml/min per 1.73 m2^ | 1.00 | 0.99, 1.02 | 0.66 |
| Recent or current immunosuppression | 0.49 | 0.14, 1.70 | 0.47 |
| Moderate or severe COVID-19 | 4.58 | 1.06, 19.86 | 0.042 |
| Outcome: Severe complications (n/N = 19/88) | Odds ratio | 95% CI | P |
| Age, years | 0.96 | 0.87, 1.06 | 0.43 |
| Sex, boys | 0.82 | 0.24, 2.79 | 0.75 |
| Nephrotic syndrome in relapse | 5.92 | 1.99, 17.66 | 0.001 |
| Estimated glomerular filtration rate, ml/min per 1.73 m2^ | 1.00 | 0.98, 1.02 | 0.81 |
| Recent or current immunosuppression | 1.87 | 0.64, 5.50 | 0.25 |
| Moderate or severe COVID-19 | 61.2 | 6.99, 536.01 | < 0.001 |
*Patients with CKD 5D were excluded from analysis
^Pre-illness, in last < 3 months